Pharmacokinetics of injectable beta-cyclodetrin inclusion complex in wistar rats

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL.1, 2012, Pages 92-95

  Li, Bao Qiu ^a   Li, Na ^b   Wang, Shu Juan ^c   Gao, Ji You ^b   Fang, Shi Hong ^b  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Hongli Laboratory Animal Experiment Co Ltd   (China)

^c Jilin Province A Think Pharmaceutical Co Ltd   (China)

Author keywords

Beta cyclodextrin; Oridonin; Pharmacokinetics; Rats

Indexed keywords

BETA CYCLODEXTRIN; ORIDONIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84858992053     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Avery MA, Muraleedharan KM, Desai PV, Bandyopadhyaya AK, Furtado MM, Tekwani BL. Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria. J Med Chem 2003; 46:4244-4258.
2. Van Nieuwerburgh FC, Vande Casteele SR, Maes L, Goossens A, Inzé D, Van Bocxlaer J, et al. Quantitation of artemisinin and its biosynthetic precursors in Artemisia annua L. by high performance liquid chromatography-electrospray quadrupole time-of-flight tandem mass spectrometry. J Chromatogr A 2006; 1118: 180-187.
3. Liu CH, Hu YY, Wang XL, Liu P, Xu LM. Effects of salvianolic acid-A on NIH/3T3 fibroblast proliferation, collagen synthesis and gene expression. World J Gastroenterol 2000; 6:361-364.
4. Wang RP, Liu C, Liu P, Zhu DY. Protective actions of salvianolic acid A on hepatocyte injured by peroxidation in vitro. World J Gastroenterol 2000; 6:402-404.
5. Gaitanis A, Staal S. Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use. Methods Mol Biol 2010;624: 385-392.
6. Chen S, Liu J, Zhang H. Efficacy of rabdosia rubescens in the treatment of gingivitis. J Huazhong Univ Sci Technolog Med Sci 2009; 29:659-663.
7. Xiao DJ, Zhu GC, Wang XL. Effects of Oridonin on proliferation in human nasopharyngeal carcinoma line CNE 2 in vitro. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007;42:780-782.
8. He XJ, Wang HJ, Xia YJ, Ye ZY, Tao HQ. Empirical study of oridonin-induced gastric cancer cells MKN45 apoptosis. Zhonghua Wei Chang Wai Ke Za Zhi 12009;12:607-610.
9. Liu YQ, You S, Tashiro S, Onodera S, Ikejima T. Oridonin induced U937 cell apoptosis through ERK pathway. Zhongguo Zhong Yao Za Zhi 2005;30:1856-1859.
10. Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T. Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway. Acta Pharmacol Sin 2004;25:691-698.
11. Cheng Y, Qiu F, Ikejima T. Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells. Autophagy 2009;5:430-431.
12. Kang N, Zhang JH, Qiu F, Chen S, Tashiro S, Onodera S, et al. Induction of G(2)/M phase arrest and apoptosis by oridonin in human laryngeal carcinoma cells. J Nat Prod 2010;73:1058-1063.
13. Zhang Y, Wu Y, Wu D, Tashiro S, Onodera S, Ikejima T. NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway. Arch Biochem Biophys 2009;489:25-33.
14. Zhang JF, Liu JJ, Liu PQ, Lin DJ, Li XD, Chen GH. Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells. Hepatol Res 2006;35:104-110.
15. Wang HJ, Li D, Yang FY, Tashiro S, Onodera S, Ikejima T. Oridonin induces human melanoma A375-S2 cell death partially through inhibiting insulin-like growth factor 1 receptor signaling. J Asian Nat Prod Res 2008;10: 787-798.
16. Liu JJ, Huang RW, Lin DJ, Wu XY, Peng J, Pan XL, Song YQ, et al. Oridonin-induced apoptosis in leukemia K562 cells and its mechanism. Neoplasma 2005;52:225-230.
17. Lou H, Zhang X, Gao L, Feng F, Wang J, Wei X, et al. In vitro and in vivo antitumor activity of oridonin nanosuspension. Int J Pharm 2009;379: 181-186.
18. Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie J, et al. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.Blood 2007;109:3441-3450.
19. Xu W, Sun J, Zhang TT, Ma B, Cui SM, Chen DW, et al. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma. Acta Pharmacol Sin 2006;27:1642-1646.
20. Mazumder R, Nath LK, Haque A, Maity T, prasanta k Choudhury PK, BHUPENDRA Shrestha B, et al. Formulation and in vitro evaluation of natural polymers based microspheres for colonic drug develivery. Int J Pharm Pharm Sci 2010; 2:211-219.
21. Panigrahy R N, Mahale AM, Dhaked PS. Formulation and in vitro evaluation of Combined floating-mucoadesive tablet of Metoprolol Succinate. Int J Pharm Pharm Sci 2011; 3:211-226.
22. Arshad Ahmed KK, Sa rfaraz Md, Doddayya HD. Design and evaluation of aceclofenac fast dissolving tablets prepared by crystallo-co-agglomeration technique. Int J Pharm Pharm Sci 2011;3:116-123.
23. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochem Biop hys Res Commun 2005;337:224-230.'
24. Ren KK, Wang HZ, Xie LP, Chen DW, Liu X, Sun J, et al. The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells. J Ethnopharmacol 2006;103:176-180.
25. Xu W, Sun J, Zhang TT, Ma B, Cui SM, Chen DW, et al. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma. Acta Pharmacol Sin 2006;27:1642-1646.
26. Ikezoe T, Yang Y, Bandobashi K, Saito T, Takemoto S, Machida H, et al. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways. Mol Cancer Ther 2005;4:578-586.